Latest Breaking News On - Barinthus biotherapeutics - Page 6 : comparemela.com

ADRs End Higher, Aesthetic Medical International Holdings Group Ltd Climbs 35 5%

ADRs End Higher, Aesthetic Medical International Holdings Group Ltd Climbs 35 5%
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAkso health groupDow jones company incBarinthus biotherapeuticsChina aesthetic medical international holdings group ltdMoatable incEmeren group ltdUk biodexa pharmaceuticalsDow jones newswiresLatin americanAesthetic medical international holdings groupHealth groupChina based emeren groupDow jones market dataDow jones

ADRs End Higher, Aesthetic Medical International Holdings Group Ltd Climbs 35 5%

This article was automatically generated by Dow Jones Newswires using technology from Automated Insights. International stocks trading in New York closed higher on Wednesday. The S&P/BNY. -April 03, 2024 at 05:12 pm EDT - MarketScreener

New yorkUnited statesChina aesthetic medical international holdings group ltdAkso health groupUk biodexa pharmaceuticalsEmeren group ltdBarinthus biotherapeuticsMoatable incDow jones newswiresLatin americanAesthetic medical international holdings groupHealth groupChina based emeren groupDow jones market dataDow jones

Redx Pharma to Quit London Stock Exchange s AIM, Citing Low Liquidity

Redx Pharma to Quit London Stock Exchange s AIM, Citing Low Liquidity
bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomNew yorkUnited statesBarinthus biotherapeuticsZura bioLondon stock exchangeRedx pharma plc

Barinthus Biotherapeutics (NASDAQ:BRNS) PT Lowered to $8 00 at HC Wainwright

Barinthus Biotherapeutics (NASDAQ:BRNS – Free Report) had its price objective cut by HC Wainwright from $15.00 to $8.00 in a research report released on Thursday, Benzinga reports. They currently have a buy rating on the stock. Separately, William Blair reaffirmed an outperform rating on shares of Barinthus Biotherapeutics in a research report on Monday, January […]

Barinthus biotherapeuticsWilliam blairFree reportGet free reportNasdaq brnsLower price targetHc wainwright

Barinthus Biotherapeutics plc (NASDAQ:BRNS) Short Interest Update

Barinthus Biotherapeutics plc (NASDAQ:BRNS – Get Free Report) was the recipient of a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 14,100 shares, a drop of 55.8% from the January 31st total of 31,900 shares. Based on an average trading volume of 12,000 shares, […]

Barinthus biotherapeuticsWilliam blairGet free reportNasdaq brns